Dark Forest Capital Management LP Charles River Laboratories International, Inc. Transaction History

Dark Forest Capital Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$203.52 - $273.43 $489,465 - $657,599	2,405 New	2,405 $651,000
Q3 2023 Nov 13, 2023	BUY	$194.44 - $217.61 $167,412 - $187,362	861 Added 31.84%	3,565 $698,000
Q2 2023 Aug 14, 2023	BUY	$183.71 - $210.25 $496,751 - $568,516	2,704 New	2,704 $568,000
Q4 2022 Feb 13, 2023	BUY	$197.11 - $250.07 $2,365 - $3,000	12 New	12 $2,000
Q2 2022 Aug 15, 2022	BUY	$204.13 - $302.4 $612 - $907	3 New	3 $1,000
Q1 2022 May 13, 2022	SELL	$255.51 - $362.11 $16,097 - $22,812	-63 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$351.38 - $448.68 $2,108 - $2,692	6 Added 10.53%	63 $24,000
Q3 2021 Nov 12, 2021	BUY	$372.64 - $458.3 $21,240 - $26,123	57 New	57 $24,000

696

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.